Crossmark

Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer

Published Online: 2025-09-27

Authors

İlhan, Nurullah

Baş, Süleyman

Alkan, Onur

Doğan, Akif

Majidova, Nargiz

Tunç, Mustafa Alperen

Erdemoğlu, Engin

Öztosun, Buğra

Ökten, İlker Nihat

Gümüş, Mahmut
License Information

Text and Data Mining valid from 2025-09-27

Version of Record valid from 2025-09-27
More Information

Article History

Received: 27 April 2025

Accepted: 18 September 2025

First Online: 27 September 2025

Declarations

:

: The authors declare no competing interests.

: This study was approved by the Ethics Committee of Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital (Approval number: 2024/300; Approval date: 18 September 2024). All participants provided written informed consent to participate.

: Not applicable.

Document is current